Gottardis Marco 4
4 · NKGen Biotech, Inc. · Filed Jul 18, 2024
Insider Transaction Report
Form 4
Gottardis Marco
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-11+300,000→ 16,667 totalExercise: $2.00→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]On July 11, 2024, the reporting person was granted 300,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in equal installments on the first of each month, beginning July 11, 2024, and ending July 11, 2027, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.